Knocking down SPAG5 increased the S-phase cell population and decreased the expression of c-MYC target genes, including the DNA repair proteins RAD51 and BRCA1/2 in triple-negative breast cancer (Li et al., 2019). The gene discussed is SPAG5; the disease is triple-negative breast carcinoma.